Insights Into The Cancer Profiling Market’s Growth Opportunities Through 2023-2032 – Includes Cancer Profiling Market Size
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The rising cancer incidence is likely to spur innovation in cancer profiling manufacturing, propelling the market throughout the forecast period.
The global cancer profiling market is expected to grow from $10.59 billion in 2022 to $11.93 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The global cancer profiling market size is expected to reach $18.29 billion in 2027 at a CAGR of 11.3%.
Get A Free Sample On The Global Cancer Profiling Market Report:
Global cancer profiling Market Segments Include:
- By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization
- By Biomarker Type: Genomic Biomarkers, Protein Biomarkers
- By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers
- By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications
- By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America is the largest region in the global cancer profiling market in 2021.
Major Market Players in the cancer profiling market include Illumina Inc., Qiagen N.V., NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine.
In the cancer profiling market, technological improvement has emerged as a prominent trend. To strengthen their market position, major market players are focusing their efforts on developing novel technologies. For example, Roche, a Swiss global healthcare business, will unveil the AVENIO Edge System in December 2021 to enhance next-generation sequencing (NGS) technology. The new AVENIO Edge System is a fully automated sample preparation system, from DNA sample input to sequencing-ready libraries output. In the future, it will allow for more complete testing with reliable and high-quality outcomes for precision medicine. It is a pre-analytical platform for sequencing library preparation, target enrichment, and quantification phases, with integrated end-to-end control and consistent, high-quality results.
The Cancer Profiling Global Market Report 2023 provides a cancer profiling market overview for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The cancer profiling market forecast analyzes cancer profiling market size, cancer profiling market share, leading competitor market positions. The regions covered in the report include Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa and the countries include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Cancer profiling is a diagnostic process that examines the genetic information of tumour cells in the body. It describes molecular or genetic alterations in a tumour, such as gene mutations or other changes in tumour DNA.
Explore Similar Reports From The Business Research Company:
Learn More About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Follow us on:
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: